Startseite>>Signaling Pathways>> Chromatin/Epigenetics>> Histone Methyltransferase>>MM-102 TFA

MM-102 TFA (Synonyms: HMTase Inhibitor IX TFA)

Katalog-Nr.GC36632

MM-102 TFA (HMTase Inhibitor IX TFA) ist ein potenter WDR5/MLL-Interaktionsinhibitor, erreicht IC50 = 2,4 nM mit einem geschÄtzten Ki, der 200-mal stÄrker ist als das ARA-Peptid.

Products are for research use only. Not for human use. We do not sell to patients.

MM-102 TFA Chemische Struktur

Cas No.: 1883545-52-5

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
202,00 $
Auf Lager
2mg
70,00 $
Auf Lager
5mg
143,00 $
Auf Lager
10mg
234,00 $
Auf Lager
50mg
821,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

MM-102 TFA (HMTase Inhibitor IX TFA) is a potent WDR5/MLL interaction inhibitor, achieves IC50 = 2.4 nM with an estimated Ki 200 times more potent than the ARA peptide. IC50: 2.4 nM (MLL)[1].

MM-102 (HMTase Inhibitor IX) inhibits MLL1 methyltransferase activity and MLL-1-induced HoxA9 and Meis-1 gene expression in leukemia cells expressing the MLL1-AF9 fusion gene. Also inhibits cell growth and induces apoptosis in leukemia cells harbouring MLL1 fusion proteins. MM-102 (TFA), with the highest binding affinities to WDR5, also show the most potent inhibitory activity in the HMT assay with IC50 = 0.4-0.9 μM. MM-102 (HMTase Inhibitor IX) dose-dependently inhibits cell growth in the MV4;11 and KOPN8 leukemia cell lines, which carry MLL1-AF4 and MLL1-ENL fusion proteins, respectively. MM-102 (HMTase Inhibitor IX) has IC50 = 25 μM in both cell lines and completely inhibits cell growth in these cell lines at 75 μM. MM-102 (HMTase Inhibitor IX) effectively and selectively inhibits cell growth and induces apoptosis in leukemia cells harboring MLL1 fusion proteins and has minimal effect in leukemia cells with wild-type MLL1 protein[1].

[1]. Karatas H, et al. High-affinity, small-molecule peptidomimetic inhibitors of MLL1/WDR5 protein-protein interaction. J Am Chem Soc. 2013 Jan 16;135(2):669-682.

Bewertungen

Review for MM-102 TFA

Average Rating: 5 ★★★★★ (Based on Reviews and 27 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MM-102 TFA

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.